APA (7th ed.) Citation

AI, H., A, B., X, L., N, I., MD, J., T, W., . . . HSL, J. (2024). Prospective Assessment of Quality of Life and Patient-Reported Toxicities Over the First Year After Chimeric Antigen Receptor T-Cell Therapy. Transplantation and cellular therapy, 30(12), 1219.e1-1219.e11. https://doi.org/10.1016/j.jtct.2024.09.013

Chicago Style (17th ed.) Citation

AI, Hoogland, et al. "Prospective Assessment of Quality of Life and Patient-Reported Toxicities Over the First Year After Chimeric Antigen Receptor T-Cell Therapy." Transplantation and Cellular Therapy 30, no. 12 (2024): 1219.e1-1219.e11. https://doi.org/10.1016/j.jtct.2024.09.013.

MLA (9th ed.) Citation

AI, Hoogland, et al. "Prospective Assessment of Quality of Life and Patient-Reported Toxicities Over the First Year After Chimeric Antigen Receptor T-Cell Therapy." Transplantation and Cellular Therapy, vol. 30, no. 12, 2024, pp. 1219.e1-1219.e11, https://doi.org/10.1016/j.jtct.2024.09.013.